Skip to main content
Clinical Trials/NCT05681793
NCT05681793
Completed
N/A

Survey on the Clinical Assessment of the Psychological Status of a Patient Over 75 Years Old in Oncology During the Realization of the G8 Score

Hopital Nord Franche-Comte1 site in 1 country200 target enrollmentJanuary 17, 2023
ConditionsDepression

Overview

Phase
N/A
Intervention
Not specified
Conditions
Depression
Sponsor
Hopital Nord Franche-Comte
Enrollment
200
Locations
1
Primary Endpoint
Comparison the medical hetero-evaluation of depressive symptoms via the G8 "neuro-psychiatric disorders" item score with a self-evaluation via the GDS-15 score, in patients over 75 years of age with cancer and follow-up in oncology
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this observational study is to make a statement concerning the identification of depressive symptoms at the time of the realization of the G8 score in patients over 75 with cancer and followed in oncology.

The main question it aims to answer are:

  • Compare the medical hetero-evaluation of depressive symptoms via the G8 "neuro-psychiatric disorders" item score with a self-evaluation via the GDS-15 score
  • Evaluate the number of patients over 75 treated with antidepressants
  • Evaluate the proportion of patients with depressive symptoms according to the predisposing factors
  • Compare the number of patients followed in oncogeriatrics over the period from 01/01/2022 to 02/28/2022 and the period from 01/01/2023 to 02/28/2023

Participants will complete a self-questionnaire (GDS-15 score) as well as a socio-demographic sheet.

Registry
clinicaltrials.gov
Start Date
January 17, 2023
End Date
April 2, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged 75 and over
  • Patients receiving treatment at the day hospital or oncology week hospital
  • Patients informed and having not presented any opposition to their participation

Exclusion Criteria

  • Patients under the age of 75
  • Patients under guardianship or curatorship
  • Patients without social security
  • Cognitive disorders compromising the understanding of the information and the performance of the study (in particular the completion of a self-administered questionnaire), in the opinion of the oncologist

Outcomes

Primary Outcomes

Comparison the medical hetero-evaluation of depressive symptoms via the G8 "neuro-psychiatric disorders" item score with a self-evaluation via the GDS-15 score, in patients over 75 years of age with cancer and follow-up in oncology

Time Frame: 2 months

Difference between the evaluation of the health professionals of the item "Neuropsychiatric problems" of the G8 score (no depression versus moderate or severe depression) and the responses of the patients to the self-administered questionnaire GDS-15 (Geriatric Depression Scale) ( 0 to 4: normal versus 5 to 15: moderate to severe depression).

Secondary Outcomes

  • Evaluation of the number of patients over 75 on antidepressants included in this study(2 months)
  • Compare the number of patients followed in oncogeriatrics over the period from 01/01/22 to 02/28/22 and the period from 01/01/2023 to 02/28/2023(2 months)
  • Evaluation of the proportion of patients with depressive symptoms according to the predisposing factors with a sociodemographic sheet and from the medical file(2 months)

Study Sites (1)

Loading locations...

Similar Trials